Prosthetic Parity: What is it
Parity is a buzzword meaning, 'on par with' or 'equal to'.
Legislative Parity is the attempt through either the State or Federal legislative process, to seek equalization. One of the most appropriate and logical applications of legislative parity is in Heath Care, specifically health insurance coverage. Legislative parity in health care means to pass legislation that equalizes insurance benefits.
So, again, what is prosthetic parity?
It is state or federal legislation requiring insurance companies to pay for prosthetic devices on par with federal programs, payment rules and regulations.
Federal Program could be Medicare, Medicaid, or programs such as the Federal Employee insurance held by Congress and other government employees. These programs provide reimbursement without capitation or exclusions for medically necessary services such as prosthetic devices.
Why is legislation necessary?
Because not all private insurance policies are created equal. While many insurances policies do pay for prosthetics without extensive requirements, there is a growing trend across the US demonstrating that private insurance companies are significantly reducing prosthetic benefits or eliminating prosthetic coverage.
The most notable change in prosthetic coverage is the 'insurance cap'. Simply put an 'insurance cap' is a yearly or lifetime benefit maximum.
The 'cap' is a common method used to limit coverage, reducing the company's financial obligation and payout, but still allowing the company to claim to offer the benefit.
Yearly caps on prosthetic services range from $500 to $3000 and lifetime restrictions range from $10,000 to one prosthetic device during a person's lifetime (from birth to death).
In a recent survey of the 20 major insurance insurers, the number of insurers with financial caps, exclusions or unusually high deductibles rose 100% during a six-year period from 2000 to 2006. All 20 insurers surveyed had implemented financial caps to prosthetic coverage.
An Explanation of Cost. These 'caps' as so important because one lower extremity prosthesis can range in cost from $5,000 to $50,000.
An upper extremity device or arm can range from $3,000 to $30,000
Why the difference and why not just give everyone the less expensive variation?
Cost does not define medical appropriateness. An amputee's daily activities, profession and certain health factors determine the specific materials and technologies used for each custom manufactured device.
As an example, the same medication is not appropriate for every person with Diabetes nor is everyone given the same analgesic after surgery.
Who does this effect?
Amputation is a catastrophic event. There is no cure. Amputation is a lifelong condition that does not go away.
Fortunately, through medical skill training and recent advances in technology the Limitations of Limb Loss can be conquered.
There are an estimated 1.9 million amputees in the United States and approximately 185,000 amputations surgeries performed each year. Of those amputations, performed 82% are due to Peripheral Vascular Disease and Diabetes.
However, there are other causes of amputation.
Approximately 8900 children receive amputations each year due to lawn mower accidents.
Birth defects result in a life long need for prosthetic devices. As of February 2007, 897 US Armed Forces personnel were in need of prosthetic devices.
Benefits of Parity Legislation.
Simply put insurance protects against catastrophic events. That is the expectation upon purchasing an insurance policy. However, it has become increasingly apparent that legislation is necessary to ensure prosthetic coverage and fair payment rules.
Individuals who pay for insurance through premiums should receive appropriate and edically necessary treatment: their arms and legs. Prosthetics provide dignity and self-reliance. Prosthetics put people back to work. In addition, by returning amputees to the workforce, strengthen a community and its economy.
About the author:
Dr Turner is a practicing psychologist, prosthetist and professor. She is also director of the American Association of Breast Care professionals and has been involved in long time advocate for the DMEPOS industry.